Skip to content

Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)

Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03585868
Acronym
COFRE
Enrollment
30
Registered
2018-07-13
Start date
2017-01-31
Completion date
2017-12-31
Last updated
2018-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frail Elderly Syndrome, Sarcopenia

Keywords

flavonoids

Brief summary

The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on anthropometric, metabolic, oxidative stress, physical performance and quality of life.

Detailed description

The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids; F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All beverages had similar physical characteristics and flavor. Cocoa beverages were provided in individual sachets containing a dry powder that was reconstituted with water just before consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30 min/day. To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein carbonylation is measured using an assay for detection of carbonyl groups that relies on 2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate interleukin-6 and tumor necrosis factor levels. For physical performance is evaluated the handgrip strength, and mobility assesment with the following test: Six-minute walk test, two-minute step, sit-up test and the up & go test. The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire.

Interventions

OTHERPlacebo

Beverage with no flavonoids

Flavonoids-enriched cacao beverage

DIETARY_SUPPLEMENTNo Flavonoids

Beverage with alkalinized cocoa which eliminates flavonoid content

Sponsors

National Polytechnic Institute, Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
55 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Sex: both * Age: 55-90 yo * Waist circumference: Women \> 80 cm, Men \> 90 cm * HDL-c: Women \< 50 mg/dL, Men \< 40 mg/dL * Triglycerides: ≥ 150 mg/dL * Glycemia: ≈100 mg/dL * Hand strength: Women\< 20 kg, Men \< 30 kg * Up & Go test: \> 10 seconds Non-inclusion criteria: * Any active infections * Malignancies * Habitual consumers of antioxidant supplements and cocoa products * Use of benzodiazepines or protein supplements

Design outcomes

Primary

MeasureTime frameDescription
Protein oxidationAt 90daysSerum protein carbonylation Levels
Blood glucoseAt 90 daysFasting blood level
Serum triacylglycerol concentrationAt 90 daysFasting blood level
Serum total cholesterolAt 90 daysFasting blood level
Serum HDL cholesterolAt 90 daysFasting blood level
Serum LDL cholesterolAt 90 daysFasting blood level
Lipid oxidationAt 90 daysSerum malondialdehyde Levels

Secondary

MeasureTime frameDescription
Handgrip strengthAt 60 daysMeasures static force in kilograms that the hand can squeeze around a dynamometer
Up and go testAt 60 daysMeasures time in seconds, a subject can rise and walk a 3-meter line and return to sit down
Six-minute walk test6 minutesMeasures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes
Two-minute step in place test2 minutesMeasures number of times a subject can rise each knee to the hip level during 2 minutes.
Sit-up test30 secondsMeasures number of times a subject can rise and sit-down in place during 30 seconds
EQ-5D questionnaireAt 60 daysSelf-administered health index that explores five domains
Analog Visual ScaleAt 60 daysUse of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026